BDBM742436 5-[[2-[7-fluoro- 6-(2,2,2- trifluoroethyl) quinazolin-4-yl]-2,7- diazaspiro[3.5]nonan- 7-yl]methyl]-4- methyl-1- [2-(4-methylsulfonyl- piperazin-1- yl)propyl]indole- 2-carbonitrile::US20250163061, Compound 30

SMILES Cc1c(CN2CCC3(CC2)CN(c2ncnc4cc(F)c(CC(F)(F)F)cc24)C3)ccc2c1cc(C#N)n2CC(C)N1CCN(S(C)(=O)=O)CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 742436   

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742436(5-[[2-[7-fluoro- 6-(2,2,2- trifluoroethyl) quinazo...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent